Pain Therapeutics, Inc. Stock Nasdaq
Equities
US69562K1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | 100M 136M | Capitalization | 1.11B 1.51B |
---|---|---|---|---|---|
Net income 2024 * | -37M -50.35M | Net income 2025 * | 17M 23.14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 11.1 x |
P/E ratio 2024 * |
-29.6
x | P/E ratio 2025 * |
64.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.39% |
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 18-09-30 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Robert Gussin
BRD | Director/Board Member | 86 | 03-02-28 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-06 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-2.47% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |